209 related articles for article (PubMed ID: 28488584)
1. Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer: a meta-analysis.
Luo G; Hu Y; Zhang Z; Wang P; Luo Z; Lin J; Cheng C; Yang Y
Oncotarget; 2017 Jul; 8(30):50273-50283. PubMed ID: 28488584
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis.
Zhang Z; Tang H; Lin J; Hu Y; Luo G; Luo Z; Cheng C; Wang P
Oncotarget; 2017 Mar; 8(10):17202-17215. PubMed ID: 28199988
[TBL] [Abstract][Full Text] [Related]
3. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
4. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Soleyman-Jahi S; Nedjat S; Abdirad A; Hoorshad N; Heidari R; Zendehdel K
PLoS One; 2014; 10(4):e0122316. PubMed ID: 25919283
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis.
Luo ZW; Zhu MG; Zhang ZQ; Ye FJ; Huang WH; Luo XZ
BMC Cancer; 2019 Feb; 19(1):123. PubMed ID: 30727976
[TBL] [Abstract][Full Text] [Related]
8. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
9. Is Overexpression of Ki-67 a Prognostic Biomarker of Upper Tract Urinary Carcinoma? A Retrospective Cohort Study and Meta-Analysis.
Fan B; Zhang H; Jin H; Gai Y; Wang H; Zong H; Jin M; Yang H; Wan S; Zhu J; Xu S; Wang J; Yang D; Song X
Cell Physiol Biochem; 2016; 40(6):1613-1625. PubMed ID: 28006766
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
Petrelli F; Viale G; Cabiddu M; Barni S
Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of prognostic role of Ki-67 labeling index in gastric carcinoma.
Pyo JS; Kim NY
Int J Biol Markers; 2017 Oct; 32(4):e447-e453. PubMed ID: 28561880
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis.
Song YX; Huang XZ; Gao P; Sun JX; Chen XW; Yang YC; Zhang C; Liu HP; Wang HC; Wang ZN
Dis Markers; 2015; 2015():549843. PubMed ID: 26576068
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
[TBL] [Abstract][Full Text] [Related]
14. MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker.
Giaginis C; Giagini A; Tsourouflis G; Gatzidou E; Agapitos E; Kouraklis G; Theocharis S
Dig Dis Sci; 2011 Mar; 56(3):777-85. PubMed ID: 20694513
[TBL] [Abstract][Full Text] [Related]
15. Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis.
Du P; Liu Y; Ren H; Zhao J; Zhang X; Patel R; Hu C; Gan J; Huang G
Gastric Cancer; 2017 Mar; 20(2):235-245. PubMed ID: 26984468
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
[TBL] [Abstract][Full Text] [Related]
17. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.
He WL; Li YH; Yang DJ; Song W; Chen XL; Liu FK; Wang Z; Li W; Chen W; Chen CY; He YL; Zhan WH
Eur J Surg Oncol; 2013 Feb; 39(2):141-9. PubMed ID: 22999412
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.
Wu JX; Zhao YY; Wu X; An HX
PLoS One; 2014; 9(12):e114746. PubMed ID: 25503963
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of phosphorylated histone H3 is an indicator of poor prognosis in gastric adenocarcinoma patients.
Takahashi H; Murai Y; Tsuneyama K; Nomoto K; Okada E; Fujita H; Takano Y
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):296-302. PubMed ID: 16932020
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.
Cheng H; Wang X; Li T; Chen L
Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]